tradingkey.logo

Allurion Technologies Inc

ALUR
1.700USD
0.000
Market hours ETQuotes delayed by 15 min
13.18MMarket Cap
LossP/E TTM

Allurion Technologies Inc

1.700
0.000
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Allurion Technologies Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Allurion Technologies Inc's Score

Industry at a Glance

Industry Ranking
190 / 485
Overall Ranking
299 / 4616
Industry
Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
5.833
Target Price
+222.28%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Allurion Technologies Inc Highlights

StrengthsRisks
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.11M.
Overvalued
The company’s latest PE is -0.01, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.18M shares, decreasing 11.77% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 3.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 5.36, which is lower than the Software & IT Services industry's average of 7.26. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 3.38M, representing a year-over-year decrease of 71.28%, while its net profit experienced a year-over-year decrease of 331.78%.

Score

Industry at a Glance

Previous score
5.36
Change
0

Financials

6.34

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

7.26

Operational Efficiency

2.57

Growth Potential

4.10

Shareholder Returns

6.53

Allurion Technologies Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 7.71, which is higher than the Software & IT Services industry's average of 7.30. Its current P/E ratio is -0.01, which is 0.00% below the recent high of -0.01 and -183144.07% above the recent low of -10.81.

Score

Industry at a Glance

Previous score
7.71
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 190/485
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 8.00, which is higher than the Software & IT Services industry's average of 7.59. The average price target for Allurion Technologies Inc is 6.00, with a high of 9.00 and a low of 2.50.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts
Buy
Current Rating
5.833
Target Price
+243.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

232
Total
9
Median
12
Average
Company name
Ratings
Analysts
Allurion Technologies Inc
ALUR
3
Microsoft Corp
MSFT
64
Palo Alto Networks Inc
PANW
55
CrowdStrike Holdings Inc
CRWD
54
Zscaler Inc
ZS
48
ServiceNow Inc
NOW
47
1
2
3
...
47

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 5.66, which is lower than the Software & IT Services industry's average of 6.56. Sideways: Currently, the stock price is trading between the resistance level at 2.04 and the support level at 1.50, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.29
Change
0.37

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(5)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.033
Sell
RSI(14)
27.893
Sell
STOCH(KDJ)(9,3,3)
13.812
Oversold
ATR(14)
0.094
Low Volatility
CCI(14)
-174.237
Sell
Williams %R
88.889
Oversold
TRIX(12,20)
-0.537
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.808
Sell
MA10
1.862
Sell
MA20
1.953
Sell
MA50
2.055
Sell
MA100
2.355
Sell
MA200
2.826
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Software & IT Services industry's average of 5.80. The latest institutional shareholding proportion is 40.95%, representing a quarter-over-quarter decrease of 28.47%. The largest institutional shareholder is The Vanguard, holding a total of 49.37K shares, representing 0.64% of shares outstanding, with 64.10% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
RTW Investments L.P.
2.54M
--
Leavitt Equity Partners III LP
462.76K
+177.66%
Armistice Capital LLC
185.00K
-52.76%
Romulus Capital Management, LLC
163.14K
--
Compute Health Sponsor LLC
130.51K
-0.00%
Gaur (Shantanu)
78.03K
+11.42%
Gupta (Krishna K.)
73.06K
--
UBS Financial Services, Inc.
62.21K
-24.27%
Olayan Investments Company Establishment
49.70K
--
The Vanguard Group, Inc.
Star Investors
49.37K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 2.64, which is lower than the Software & IT Services industry's average of 4.86. The company's beta value is -0.46. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.64
Change
0
Beta vs S&P 500 index
-0.45
VaR
--
240-Day Maximum Drawdown
+86.69%
240-Day Volatility
+222.99%

Return

Best Daily Return
60 days
+12.56%
120 days
+23.73%
5 years
--
Worst Daily Return
60 days
-6.57%
120 days
-11.29%
5 years
--
Sharpe Ratio
60 days
-3.19
120 days
-0.60
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+86.69%
3 years
+99.36%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.95
3 years
-0.33
5 years
--
Skewness
240 days
+6.24
3 years
+7.63
5 years
--

Volatility

Realised Volatility
240 days
+222.99%
5 years
--
Standardised True Range
240 days
+33.41%
5 years
--
Downside Risk-Adjusted Return
120 days
-118.89%
240 days
-118.89%
Maximum Daily Upside Volatility
60 days
+38.05%
Maximum Daily Downside Volatility
60 days
+41.57%

Liquidity

Average Turnover Rate
60 days
+1.92%
120 days
+654.50%
5 years
--
Turnover Deviation
20 days
-99.72%
60 days
-99.53%
120 days
+59.78%

Peer Comparison

Software & IT Services
Allurion Technologies Inc
Allurion Technologies Inc
ALUR
5.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
Amdocs Ltd
DOX
8.95 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CACI International Inc
CACI International Inc
CACI
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cognizant Technology Solutions Corp
Cognizant Technology Solutions Corp
CTSH
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Appfolio Inc
Appfolio Inc
APPF
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Leidos Holdings Inc
Leidos Holdings Inc
LDOS
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI